Germline selection of PTPN11 (HGNC:9644) variants make a major contribution to both Noonan syndrome's high birth rate and the transmission of sporadic cancer variants resulting in fetal abnormality

被引:3
作者
Eboreime, Jordan [1 ]
Choi, Soo-Kyung [1 ]
Yoon, Song-Ro [1 ]
Sadybekov, Anastasiia [2 ]
Katritch, Vsevolod [2 ]
Calabrese, Peter [3 ]
Arnheim, Norman [1 ]
机构
[1] Univ Southern Calif, Dept Biol Sci, Mol & Computat Biol Program, Los Angeles, CA 90007 USA
[2] Univ Southern Calif, Bridge Inst, Dept Chem, Los Angeles, CA USA
[3] Univ Southern Calif, Dept Quantitat & Computat Biol, Los Angeles, CA 90007 USA
基金
美国国家卫生研究院;
关键词
fetal abnormality; germline selection; Noonan syndrome; RASopathies; sporadic cancer; SSC clonal expansion; JUVENILE MYELOMONOCYTIC LEUKEMIA; AMINO-ACID SUBSTITUTIONS; MUTATION-RATE; STEM-CELL; POSITIVE SELECTION; FGFR2; MUTATIONS; MALE-FERTILITY; SHP2; PROTEIN; DISORDERS; SPECTRUM;
D O I
10.1002/humu.24493
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Some spontaneous germline gain-of-function mutations promote spermatogonial stem cell clonal expansion and disproportionate variant sperm production leading to unexpectedly high transmission rates for some human genetic conditions. To measure the frequency and spatial distribution of de novo mutations we divided three testes into 192 pieces each and used error-corrected deep-sequencing on each piece. We focused on PTPN11 (HGNC:9644) Exon 3 that contains 30 different PTPN11 Noonan syndrome (NS) mutation sites. We found 14 of these variants formed clusters among the testes; one testis had 11 different variant clusters. The mutation frequencies of these different clusters were not correlated with their case-recurrence rates nor were case recurrence rates of PTPN11 variants correlated with their tyrosine phosphatase levels thereby confusing PTPN11's role in germline clonal expansion. Six of the PTPN11 exon 3 de novo variants associated with somatic mutation-induced sporadic cancers (but not NS) also formed testis clusters. Further, three of these six variants were observed among fetuses that underwent prenatal ultrasound screening for NS-like features. Mathematical modeling showed that germline selection can explain both the mutation clusters and the high incidence of NS (1/1000-1/2500).
引用
收藏
页码:2205 / 2221
页数:17
相关论文
共 86 条
  • [51] Diverse driving forces underlie the invariant occurrence of the T42A, E139D, I282V and T468M SHP2 amino acid substitutions causing Noonan and LEOPARD syndromes
    Martinelli, Simone
    Torreri, Paola
    Tinti, Michele
    Stella, Lorenzo
    Bocchinfuso, Gianfranco
    Flex, Elisabetta
    Grottesi, Alessandro
    Ceccarini, Marina
    Palleschi, Antonio
    Cesareni, Gianni
    Castagnoli, Luisa
    Petrucci, Tamara C.
    Gelb, Bruce D.
    Tartaglia, Marco
    [J]. HUMAN MOLECULAR GENETICS, 2008, 17 (13) : 2018 - 2029
  • [52] Counteracting Effects Operating on Src Homology 2 Domain-containing Protein-tyrosine Phosphatase 2 (SHP2) Function Drive Selection of the Recurrent Y62D and Y63C Substitutions in Noonan Syndrome
    Martinelli, Simone
    Nardozza, Aurelio P.
    Delle Vigne, Silvia
    Sabetta, Gilda
    Torreri, Paola
    Bocchinfuso, Gianfranco
    Flex, Elisabetta
    Venanzi, Serenella
    Palleschi, Antonio
    Gelb, Bruce D.
    Cesareni, Gianni
    Stella, Lorenzo
    Castagnoli, Luisa
    Tartaglia, Marco
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (32) : 27066 - 27077
  • [53] Juvenile myelomonocytic leukemia-associated variants are associated with neo-natal lethal Noonan syndrome
    Mason-Suares, Heather
    Toledo, Diana
    Gekas, Jean
    Lafferty, Katherine A.
    Meeks, Naomi
    Pacheco, M. Cristina
    Sharpe, David
    Mullen, Thomas E.
    Lebo, Matthew S.
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2017, 25 (04) : 509 - 511
  • [54] The role of Shp2 (PTPN11) in cancer
    Mohi, M. Golam
    Neel, Benjamin G.
    [J]. CURRENT OPINION IN GENETICS & DEVELOPMENT, 2007, 17 (01) : 23 - 30
  • [55] Protein tyrosine phosphatase SHP2/PTPN11 mistargeting as a consequence of SH2-domain point mutations associated with Noonan Syndrome and leukemia
    Mueller, Pia J.
    Rigbolt, Kristoffer T. G.
    Paterok, Dirk
    Piehler, Jacob
    Vanselow, Jens
    Lasonder, Edwin
    Andersen, Jens S.
    Schaper, Fred
    Sobota, Radoslaw M.
    [J]. JOURNAL OF PROTEOMICS, 2013, 84 : 132 - 147
  • [56] Nachman MW, 2000, GENETICS, V156, P297
  • [57] The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling
    Neel, BG
    Gu, HH
    Pao, L
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 2003, 28 (06) : 284 - 293
  • [58] Functional analysis of PTPN11/SHP-2 mutants identified in Noonan syndrome and childhood leukemia
    Niihori, T
    Aoki, Y
    Ohashi, H
    Kurosawa, K
    Kondoh, T
    Ishikiriyama, S
    Kawame, H
    Kamasaki, H
    Yamanaka, T
    Takada, F
    Nishio, K
    Sakurai, M
    Tamai, H
    Nagashima, T
    Suzuki, Y
    Kure, S
    Fujii, K
    Imaizumi, M
    Matsubara, Y
    [J]. JOURNAL OF HUMAN GENETICS, 2005, 50 (04) : 192 - 202
  • [59] Classification of Amino Acid Substitutions in Mismatch Repair Proteins Using PON-MMR2
    Niroula, Abhishek
    Vihinen, Mauno
    [J]. HUMAN MUTATION, 2015, 36 (12) : 1128 - 1134
  • [60] Regulation of Mouse Spermatogonial Stem Cell Differentiation by STAT3 Signaling
    Oatley, Jon M.
    Kaucher, Amy V.
    Avarbock, Mary R.
    Brinster, Ralph L.
    [J]. BIOLOGY OF REPRODUCTION, 2010, 83 (03) : 427 - 433